Search
The prevalence of HIV in the United States is currently 1.2 million, peaking between the ages of 20 and 30 years of age, while AIDS peaks at close to 45 years of age.
By Andrew M. SeamanA national TV ad campaign featuring real people with smoking-related diseases may have helped encourage others to kick the tobacco habit, according to U.S. health officials.The campaign, known as "Tips from Former Smokers," ran between March and June 2012 across the U.S. and reached about four of every five smokers.While it was running, 1.6 million smokers attempted to quit, and more than 100,000 kicked the habit, researchers say.
Dr Laxmi Mehta, from Ohio State University, talks about how treatment options differ between men and women who present with myocardial infarction and how to prevent a subsequent infarction.
Consultant360 reached out to study author Timothy M. Cook, MBBS, about a recent study examining in-ICU mortality rates among patients with COVID-19.
Non-celiac gluten sensitivity does not appear to exist when tested for under controlled conditions.
By Dipika Jain and Subrat Patnaik(Reuters) - Acadia Pharmaceuticals Inc's drug for psychosis linked to Parkinson's disease was approved in the United States on Friday, becoming the first treatment for the condition to get a nod in the country.
<p>Older men who take vitamin E and selenium supplements have the same risk of dementia as people who don't use these products.</p>
The new oral treatment for multiple sclerosis is indicated for patients with clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
In this podcast, Viral Shah MD, Professor of Medicine in the Division of Endocrinology and Metabolism at the Indiana University School of Medicine and Chair of the American Diabetes Association (ADA) Diabetes Technology Interest Group discusses new advancements in the field of diabetes technology, what excites him about diabetes technology when looking ahead, the goals and objectives of the ADA Diabetes Technology Interest Group, and more.
By Anne HardingNEW YORK (Reuters Health) - Children with attention-deficit/hyperactivity disorder (ADHD) are at lower risk of injury when they are on medication, especially brain injury, new findings suggest.
Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the effects of the new American Diabetes Association recommendations on the usage of these therapeutics.
Modern digital media platforms are increasingly popular and accessible, but it is not yet clear whether digital media use is associated with the occurrence of ADHD symptoms. In a new study, researchers explored this potential link further.
In this podcast, William R. Hiatt, MD, provides insight into a new subgroup analysis of the VOYAGER-PAD trial, which revealed whether adding clopidogrel to the rivaroxaban and aspirin regime of a patient with peripheral artery disease at the time of revascularization is beneficial.
A CDC official’s talk about ADHD drugs in 2- and 3-year-olds at a small Georgia event has gone viral. Prepare to answer pointed questions from parents. (CDC photo)
In a recent study, researchers aimed to better understand the prevalence of hepatitis C virus in the global population.
<p>Replacing standard packaging with single-serve packaging may help some overweight people to consume less food.</p>